MINIMAL RESIDUAL DISEASE DETECTION
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study (Rawstron, Leukemia, 2016)
Improving efficiency and sensitivity: ERIC update on the international harmonised approach for flow cytometric residual disease monitoring in CLL (Rawstron, Leukemia, 2013)
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia (Rawstron, Leukemia 2007)